Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early Prognostic Evaluation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 0 results

Not applicableActive Not RecruitingNCT06876402
What this trial is testing

Gene Molecular Alterations as Disease Prognostic Markers in Patients With Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)
Hellenic Cooperative Oncology Group 367
Not applicableLooking for participantsNCT00512239
What this trial is testing

Prognostic Evaluation of Inflammatory Polyarthritis of Recent Onset

Who this might be right for
Rheumatoid ArthritisInflammatory Arthritis
Gilles Boire 1,000
Large-scale testing (Phase 3)UnknownNCT02097459
What this trial is testing

Prognostic Evaluation of Changing Endocrine Therapy in Women With Breast Cancer

Who this might be right for
Breast Cancer
Peking Union Medical College Hospital 600
Not applicableNot Yet RecruitingNCT05155358
What this trial is testing

Study on the Establishment of a System for Early Warning and Prognostic Evaluation of Patients With Heat Stroke

Who this might be right for
Heat StrokeEarly WakingMODS+3 more
Xijing Hospital 150
Not applicableUnknownNCT06409039
What this trial is testing

POLE-END REAL LIFE: Endometrial Cancer Early Stages I-II and Advanced Stages III and IV Evaluation of POLE as a Prognostic Factor. Participants Are Women >= 18 Years Old, With the Pole Mutation

Who this might be right for
Endometrial Neoplasms
Azienda Ulss 2 Marca Trevigiana 80
Large-scale testing (Phase 3)Study completedNCT04673214
What this trial is testing

Evaluation of Prognostic Modification in COVID-19 Patients in Early Intervention Treatment

Who this might be right for
Covid19
Gilberto Cruz Arteaga 114